The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the world’s leading producer of gene-sequencing machines ...

The expansion of clones with distinct SERPINA1 somatic mutants in the livers of alpha-1 antitrypsin deficiency (A1AT) patients is consistent with convergent evolution. These variants interfere ...

Authorities have also targeted US businesses operating in the country, for example by banning the import of Illumina gene-sequencing machines into China, effectively stemming its growth in the market.